KMKNX
Price
$81.51
Change
-$0.36 (-0.44%)
Updated
Jun 2 closing price
Net Assets
289.25M
PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

KMKNX vs PMBCX

Header iconKMKNX vs PMBCX Comparison
Open Charts KMKNX vs PMBCXBanner chart's image
KMKNX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
KMKNX vs. PMBCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMKNX is a Hold and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. KMKNX (289M). KMKNX pays higher dividends than PMBCX: KMKNX (0.15) vs PMBCX (0.00). KMKNX was incepted earlier than PMBCX: KMKNX (20 years) vs PMBCX (19 years). PMBCX (1.71) and KMKNX (1.68) have similar cost to investors . PMBCX is a more actively managed with annual turnover of: 13.70 vs. KMKNX (4.00). PMBCX has a lower initial minimum investment than KMKNX: PMBCX (1000) vs KMKNX (2500). KMKNX annual gain was more profitable for investors over the last year : 0.13 vs. PMBCX (-15.11). KMKNX return over 5 years is better than : 99.01 vs. PMBCX (-9.16).
KMKNXPMBCXKMKNX / PMBCX
Total Expense Ratio1.401.7182%
Annual Report Gross Expense Ratio1.681.7198%
Fund Existence20 years19 years-
Gain YTD11.267-7.252-155%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets289M24.6B1%
Annual Yield % from dividends0.150.00-
Returns for 1 year0.13-15.11-1%
Returns for 3 years133.939.971,343%
Returns for 5 years99.01-9.16-1,081%
Returns for 10 years430.5953.20809%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity